Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection. (2021)
Attributed to:
Stratified Medicine to Optimise Treatment for Hepatitis C Virus Infection
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jhepr.2021.100384
PubMed Identifier: 34805817
Publication URI: http://europepmc.org/abstract/MED/34805817
Type: Journal Article/Review
Volume: 3
Parent Publication: JHEP reports : innovation in hepatology
Issue: 6
ISSN: 2589-5559